| FEGOX | FGDTX | FEGOX / FGDTX | |
| Total Expense Ratio | 1.91 | 1.22 | 157% |
| Annual Report Gross Expense Ratio | 1.91 | 1.22 | 157% |
| Fund Existence | 23 years | 19 years | - |
| Gain YTD | 9.220 | 24.776 | 37% |
| Front Load | N/A | 4% | - |
| Min. Initial Investment | 2500 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 5.77B | 4.93B | 117% |
| Annual Yield % from dividends | 0.63 | 1.98 | 32% |
| Returns for 1 year | 118.61 | 166.66 | 71% |
| Returns for 3 years | 172.12 | 222.16 | 77% |
| Returns for 5 years | 165.17 | 175.24 | 94% |
| Returns for 10 years | 377.13 | 396.01 | 95% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GSITX | 64.67 | 0.94 | +1.47% |
| Goldman Sachs Small Cp Val Insghts Instl | |||
| BUFOX | 16.90 | 0.21 | +1.26% |
| Buffalo Early Stage Growth Fd | |||
| PCCOX | 68.92 | 0.44 | +0.64% |
| T. Rowe Price U.S. Equity Research I | |||
| TFFAX | 9.98 | 0.06 | +0.60% |
| Templeton Foreign Adv | |||
| DRLAX | 8.95 | -0.07 | -0.78% |
| BNY Mellon Developed Markets RE Scs - A | |||